cbdc token Top Top stories

The yield of China's 10-year government bonds fell below 1.80% at the beginning of the session, hitting a new record low.Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.

A spokesman for UnitedHealth Group said that the mother of Mangione, a suspect accused of shooting a company executive, also had no insurance for UnitedHealth.CITIC Jiantou: The food and beverage industry is expected to usher in an inflection point. The CITIC Jiantou research report pointed out that 1) focusing on boosting consumption and expanding effective domestic demand, the food and beverage industry is expected to usher in an inflection point, and its performance and valuation are expected to continue to improve. The liquor sector is expected to rebound with the boost of the domestic economy and the activation of household consumption, and the business scene and mass consumption boom will return to the consumption upgrading channel, and the profitability of leading liquor companies is expected to accelerate the repair. At present, the overall valuation of the liquor sector is still at a low level, and the long-term investment value is prominent. 2) With the increase of policy stimulus, the pro-cyclical catering chain is expected to take the lead in benefiting from the expected improvement. Continue to be optimistic: 1) The leisure snacks and beverage industries maintain a high degree of prosperity, and new channels bring important incremental opportunities to companies in the industry; 2) In combination with the catering channels that continue to recover, it is suggested to pay attention to condiments, beer and catering chain labels with innovative products or reform expectations, and at the same time, the current molasses market price is further reduced from the previous month, which is of great help to yeast enterprises to improve their profit elasticity; 3) The inflection point of the raw milk cycle is approaching, the gift scene is expected to be repaired, and the dairy products continue to upgrade their structure, with high dividends and outstanding cost performance.Guotai Junan: It is expected that the lithium price will fluctuate in the bottom range in 2025, and there is a strong opportunity and space for rebound. Guotai Junan Securities recently reported that the lithium price has entered the bottom range by the end of 2024. If the demand maintains the current neutral estimate in 2025, the lithium price will fluctuate in the bottom range. At present, the market is optimistic about the demand in 2025, and the industry supply has slowed down. It is estimated that the price trend of lithium will fluctuate in the bottom range in 2025, in which the stage is affected by seasonal factors and there is a strong rebound opportunity and space. The market expected the trading of lithium plate earlier, that is, when the commodity price bottomed out, the lithium plate already contained the expectation of industrial clearing. When the industry actually enters the stage of supply and clearing, the sector will trade commodity price reversal expectations. From this, we infer that the rise of lithium plate will start before the spot price reverses.

Xiaomi Automobile is speeding up its voyage to sea, and will carry out automobile sales business in many regions. According to 36Kr, it is learned from many sources that Xiaomi is preparing to build automobile voyage business. Under the international department of the Group, Xiaomi has added a preparatory group for overseas sales business, and positions such as market research, project management and after-sales engineer of electric vehicles are being recruited. Under the Ministry of Automobile, Xiaomi's autonomous driving department has added a number of jobs for overseas markets to solve the problem of overseas legal verification and function landing of autonomous driving function. It is foreseeable that autonomous driving will be one of the key points of Xiaomi Automobile's betting on the sea. According to people familiar with the matter, after the formation of the team, Xiaomi will carry out small-batch car sales in many overseas regions, test the market reaction, and prepare for the large-scale development of sea business.The memorial hall for the victims of the Nanjing Massacre by the Japanese invaders held a ceremony to raise the national flag and fly it at half mast. (CCTV)Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.